CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Search results
>
Research work
journal article text
Supplementary Methods from Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
Authors
Adnan M. Nagrial (14993022)
Andrew V. Biankin (7954910)
+9 more
Angela Chou (519815)
Fares Al-Ejeh (266674)
Kum Kum Khanna (11619798)
Marina Pajic (132629)
Mariska Miranda (14956479)
Michael P. Brown (9654366)
Murugan Kalimutho (6375365)
Sean M. Grimmond (132666)
Wei Shi (68167)
Publication date
15 June 2014
Publisher
Doi
Abstract
Detailed methods of: EGFR immunohistochemistry of PDAC tissue microarrays Patient derived xenografts (PDXs) and cell lines (PDCLs) generation Cell culture Treatments in vitro Histological and immunoblotting analyses of PDXs post-treatment</p
Similar works
Full text
Available Versions
The Francis Crick Institute
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:figshare.com:article/22456...
Last time updated on 02/04/2023
